Skip to main content
Top
Published in: African Journal of Urology 1/2020

Open Access 01-12-2020 | Prostate Cancer | Short Communications

COVID-19: the androgen hypothesis

Authors: Jeff John, Ken Kesner

Published in: African Journal of Urology | Issue 1/2020

Login to get access

Excerpt

On December 31, 2019, the World Health Organisation (WHO) China Office was informed of patients presenting with pneumonia of unknown aetiology in Wuhan City in the Hubei Province of China. Twelve days later, China revealed the genetic sequence of the causative agent, a novel virus which the WHO named SARS Coronavirus 2 (SARS-CoV-2) and the resulting pneumonia Coronavirus Disease 2019 (COVID-19) [1]. At the time of writing, there have been 14,530,395 reported cases and 606,760 deaths (6.26%) worldwide. The African continent, home to 17% of the world’s population, currently accounts for just 4.9% of cases and 2.5% of deaths [2]. …
Literature
1.
go back to reference John J, Kesner K (2020) COVID-19: No longer status quo for the surgeon. S Afr J Surg 58(2):53–54 John J, Kesner K (2020) COVID-19: No longer status quo for the surgeon. S Afr J Surg 58(2):53–54
4.
go back to reference Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271.e8–280.e8CrossRef Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271.e8–280.e8CrossRef
5.
go back to reference Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I et al (2020) Enhanced isolation of SARS-CoV-2 by TMPRSS2- expressing cells. Proc Natl Acad Sci USA 117(13):7001–7003CrossRef Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I et al (2020) Enhanced isolation of SARS-CoV-2 by TMPRSS2- expressing cells. Proc Natl Acad Sci USA 117(13):7001–7003CrossRef
7.
go back to reference Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pohlmann S (2014) TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 88(2):1293–1307CrossRef Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pohlmann S (2014) TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 88(2):1293–1307CrossRef
8.
go back to reference Shen LW, Mao HJ, Wu YL, Tanaka Y, Zhang W (2017) TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie 142:1–10CrossRef Shen LW, Mao HJ, Wu YL, Tanaka Y, Zhang W (2017) TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie 142:1–10CrossRef
9.
go back to reference Sharifi N, Ryan CJ (2020) Androgen hazards with COVID-19. Endocr Relat Cancer 27(6):E1–E3CrossRef Sharifi N, Ryan CJ (2020) Androgen hazards with COVID-19. Endocr Relat Cancer 27(6):E1–E3CrossRef
12.
go back to reference Montanõ LM, Espinoza J, Flores-Soto E, Chávez J, Perusquiá M (2014) Androgens are bronchoactive drugs that act by relaxing airway smooth muscle and preventing bronchospasm. J Endocrinol 222(1):1–13CrossRef Montanõ LM, Espinoza J, Flores-Soto E, Chávez J, Perusquiá M (2014) Androgens are bronchoactive drugs that act by relaxing airway smooth muscle and preventing bronchospasm. J Endocrinol 222(1):1–13CrossRef
13.
go back to reference Trigunaite A, Dimo J, Jørgensen TN (2015) Suppressive effects of androgens on the immune system. Cell Immunol 294(2):87–94CrossRef Trigunaite A, Dimo J, Jørgensen TN (2015) Suppressive effects of androgens on the immune system. Cell Immunol 294(2):87–94CrossRef
16.
go back to reference Suba Z (2020) Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J Pharm Pharm Sci 23:75–85CrossRef Suba Z (2020) Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J Pharm Pharm Sci 23:75–85CrossRef
Metadata
Title
COVID-19: the androgen hypothesis
Authors
Jeff John
Ken Kesner
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
African Journal of Urology / Issue 1/2020
Print ISSN: 1110-5704
Electronic ISSN: 1961-9987
DOI
https://doi.org/10.1186/s12301-020-00075-0

Other articles of this Issue 1/2020

African Journal of Urology 1/2020 Go to the issue